Skip to main content
Erschienen in: Journal of Neurology 2/2017

04.11.2016 | Original Communication

Factors associated with fatal outcome in posterior reversible encephalopathy syndrome: a retrospective analysis of the Berlin PRES study

verfasst von: Eberhard Siebert, G. Bohner, T. Liebig, M. Endres, T. G. Liman

Erschienen in: Journal of Neurology | Ausgabe 2/2017

Einloggen, um Zugang zu erhalten

Abstract

Although often reversible, fatal outcome in posterior reversible encephalopathy syndrome (PRES) is well known. However, data on predictors of PRES-associated in-hospital death are scarce. In this study, we aimed to investigate predictors of in-hospital death in a large cohort. Radiological report databases between January 1999 and February 2015 were retrospectively searched for patients with PRES. Patients were included if they met criteria for PRES after detailed investigation of clinical charts and imaging studies. Various clinical, paraclinical and brain MRI data as well as data on in-hospital mortality were analyzed. 151 patients were included into the study, 64% were female. Seventeen (11.2%) patients died during hospital stay. In univariate analyses, higher age (p = 0.04), higher levels of C-reactive protein (p < 0.001), etiology of PRES (sepsis and chemotherapy; p = 0.02), altered coagulation (p = 0.002), altered mental state at onset (p = 0.03), and subarachnoid hemorrhage (SAH; p = 0.01) were related to in-hospital death. In multivariate analyses adjusted for age and sex, elevated CRP levels (OR 1.1 95% CI 1.1–1.2), altered coagulation (OR 5.1 95% CI 1.8–14.7), subarachnoid hemorrhage (OR 10.1 95% CI 2.2–46.1) and altered mental state (OR 3.3; 95% CI 1.1–9.4) were independently associated with in-hospital death. Altered mental state, subarachnoid hemorrhage as well as the higher levels of CRP and altered coagulation were significantly more frequent in patients who died in hospital. However, prospective studies are warranted to establish predictors of fatality in patients with PRES.
Literatur
3.
Zurück zum Zitat Liman TG, Bohner G, Heuschmann PU, Endres M, Siebert E (2012) The clinical and radiological spectrum of posterior reversible encephalopathy syndrome: the retrospective Berlin PRES study. J Neurol 259(1):155–164. doi:10.1007/s00415-011-6152-4 CrossRefPubMed Liman TG, Bohner G, Heuschmann PU, Endres M, Siebert E (2012) The clinical and radiological spectrum of posterior reversible encephalopathy syndrome: the retrospective Berlin PRES study. J Neurol 259(1):155–164. doi:10.​1007/​s00415-011-6152-4 CrossRefPubMed
4.
5.
6.
8.
Zurück zum Zitat Neeb L, Hoekstra J, Endres M, Siegerink B, Siebert E, Liman TG (2016) Spectrum of cerebral spinal fluid findings in patients with posterior reversible encephalopathy syndrome. J Neurol. doi:10.1007/s00415-015-7928-8 PubMed Neeb L, Hoekstra J, Endres M, Siegerink B, Siebert E, Liman TG (2016) Spectrum of cerebral spinal fluid findings in patients with posterior reversible encephalopathy syndrome. J Neurol. doi:10.​1007/​s00415-015-7928-8 PubMed
9.
Zurück zum Zitat Bartynski WS, Boardman JF, Zeigler ZR, Shadduck RK, Lister J (2006) Posterior reversible encephalopathy syndrome in infection, sepsis, and shock. Am J Neuroradiol 27(10):2179–2190PubMed Bartynski WS, Boardman JF, Zeigler ZR, Shadduck RK, Lister J (2006) Posterior reversible encephalopathy syndrome in infection, sepsis, and shock. Am J Neuroradiol 27(10):2179–2190PubMed
10.
Zurück zum Zitat Legriel S, Schraub O, Azoulay E, Hantson P, Magalhaes E, Coquet I, Bretonniere C, Gilhodes O, Anguel N, Megarbane B, Benayoun L, Schnell D, Plantefeve G, Charpentier J, Argaud L, Mourvillier B, Galbois A, Chalumeau-Lemoine L, Rivoal M, Durand F, Geffroy A, Simon M, Stoclin A, Pallot JL, Arbelot C, Nyunga M, Lesieur O, Troche G, Bruneel F, Cordoliani YS, Bedos JP, Pico F (2012) Determinants of recovery from severe posterior reversible encephalopathy syndrome. PLoS One 7(9):e44534. doi:10.1371/journal.pone.0044534 CrossRefPubMedPubMedCentral Legriel S, Schraub O, Azoulay E, Hantson P, Magalhaes E, Coquet I, Bretonniere C, Gilhodes O, Anguel N, Megarbane B, Benayoun L, Schnell D, Plantefeve G, Charpentier J, Argaud L, Mourvillier B, Galbois A, Chalumeau-Lemoine L, Rivoal M, Durand F, Geffroy A, Simon M, Stoclin A, Pallot JL, Arbelot C, Nyunga M, Lesieur O, Troche G, Bruneel F, Cordoliani YS, Bedos JP, Pico F (2012) Determinants of recovery from severe posterior reversible encephalopathy syndrome. PLoS One 7(9):e44534. doi:10.​1371/​journal.​pone.​0044534 CrossRefPubMedPubMedCentral
11.
15.
Zurück zum Zitat Hinduja A, Habetz K, Raina S, Ramakrishnaiah R, Fitzgerald RT (2016) Predictors of poor outcome in patients with posterior reversible encephalopathy syndrome. Int J Neurosci. doi:10.3109/00207454.2016.1152966 Hinduja A, Habetz K, Raina S, Ramakrishnaiah R, Fitzgerald RT (2016) Predictors of poor outcome in patients with posterior reversible encephalopathy syndrome. Int J Neurosci. doi:10.​3109/​00207454.​2016.​1152966
16.
Zurück zum Zitat Liman TG, Bohner G, Heuschmann PU, Scheel M, Endres M, Siebert E (2012) Clinical and radiological differences in posterior reversible encephalopathy syndrome between patients with preeclampsia-eclampsia and other predisposing diseases. Eur J Neurol. doi:10.1111/j.1468-1331.2011.03629 PubMed Liman TG, Bohner G, Heuschmann PU, Scheel M, Endres M, Siebert E (2012) Clinical and radiological differences in posterior reversible encephalopathy syndrome between patients with preeclampsia-eclampsia and other predisposing diseases. Eur J Neurol. doi:10.​1111/​j.​1468-1331.​2011.​03629 PubMed
17.
Zurück zum Zitat Mueller-Mang C, Mang T, Pirker A, Klein K, Prchla C, Prayer D (2009) Posterior reversible encephalopathy syndrome: do predisposing risk factors make a difference in MRI appearance? Neuroradiology 51(6):373–383. doi:10.1007/s00234-009-0504-0 CrossRefPubMed Mueller-Mang C, Mang T, Pirker A, Klein K, Prchla C, Prayer D (2009) Posterior reversible encephalopathy syndrome: do predisposing risk factors make a difference in MRI appearance? Neuroradiology 51(6):373–383. doi:10.​1007/​s00234-009-0504-0 CrossRefPubMed
18.
Zurück zum Zitat Junewar V, Verma R, Sankhwar PL, Garg RK, Singh MK, Malhotra HS, Sharma PK, Parihar A (2014) Neuroimaging features and predictors of outcome in eclamptic encephalopathy: a prospective observational study. Am J Neuroradiol 35(9):1728–1734. doi:10.3174/ajnr.A3923 CrossRefPubMed Junewar V, Verma R, Sankhwar PL, Garg RK, Singh MK, Malhotra HS, Sharma PK, Parihar A (2014) Neuroimaging features and predictors of outcome in eclamptic encephalopathy: a prospective observational study. Am J Neuroradiol 35(9):1728–1734. doi:10.​3174/​ajnr.​A3923 CrossRefPubMed
19.
Zurück zum Zitat Choi S, Park K, Ryu S, Kang T, Kim H, Cho S, Oh S (2016) Use of S-100B, NSE, CRP and ESR to predict neurological outcomes in patients with return of spontaneous circulation and treated with hypothermia. Emerg Med J. doi:10.1136/emermed-2015-205423 Choi S, Park K, Ryu S, Kang T, Kim H, Cho S, Oh S (2016) Use of S-100B, NSE, CRP and ESR to predict neurological outcomes in patients with return of spontaneous circulation and treated with hypothermia. Emerg Med J. doi:10.​1136/​emermed-2015-205423
20.
Zurück zum Zitat Di Napoli M, Elkind MS, Godoy DA, Singh P, Papa F, Popa-Wagner A (2011) Role of C-reactive protein in cerebrovascular disease: a critical review. Expert Rev Cardiovasc Ther 9(12):1565–1584. doi:10.1586/erc.11.159 CrossRefPubMed Di Napoli M, Elkind MS, Godoy DA, Singh P, Papa F, Popa-Wagner A (2011) Role of C-reactive protein in cerebrovascular disease: a critical review. Expert Rev Cardiovasc Ther 9(12):1565–1584. doi:10.​1586/​erc.​11.​159 CrossRefPubMed
23.
Zurück zum Zitat Turner CL, Budohoski K, Smith C, Hutchinson PJ, Kirkpatrick PJ, Murray GD (2015) Elevated baseline C-reactive protein as a predictor of outcome after aneurysmal subarachnoid hemorrhage: data from the simvastatin in aneurysmal subarachnoid hemorrhage (STASH) trial. Neurosurgery 77(5):786–792. doi:10.1227/NEU.0000000000000963 (discussion 792–783) CrossRefPubMedPubMedCentral Turner CL, Budohoski K, Smith C, Hutchinson PJ, Kirkpatrick PJ, Murray GD (2015) Elevated baseline C-reactive protein as a predictor of outcome after aneurysmal subarachnoid hemorrhage: data from the simvastatin in aneurysmal subarachnoid hemorrhage (STASH) trial. Neurosurgery 77(5):786–792. doi:10.​1227/​NEU.​0000000000000963​ (discussion 792–783) CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Hefzy HM, Bartynski WS, Boardman JF, Lacomis D (2009) Hemorrhage in posterior reversible encephalopathy syndrome: imaging and clinical features. Am J Neuroradiol 30(7):1371–1379. doi:10.3174/ajnr.A1588 CrossRefPubMed Hefzy HM, Bartynski WS, Boardman JF, Lacomis D (2009) Hemorrhage in posterior reversible encephalopathy syndrome: imaging and clinical features. Am J Neuroradiol 30(7):1371–1379. doi:10.​3174/​ajnr.​A1588 CrossRefPubMed
27.
Zurück zum Zitat McKinney AM, Short J, Truwit CL, McKinney ZJ, Kozak OS, SantaCruz KS, Teksam M (2007) Posterior reversible encephalopathy syndrome: incidence of atypical regions of involvement and imaging findings. Am J Roentgenol 189(4):904–912. doi:10.2214/AJR.07.2024 CrossRef McKinney AM, Short J, Truwit CL, McKinney ZJ, Kozak OS, SantaCruz KS, Teksam M (2007) Posterior reversible encephalopathy syndrome: incidence of atypical regions of involvement and imaging findings. Am J Roentgenol 189(4):904–912. doi:10.​2214/​AJR.​07.​2024 CrossRef
28.
Zurück zum Zitat Moon SN, Jeon SJ, Choi SS, Song CJ, Chung GH, Yu IK, Kim DH (2013) Can clinical and MRI findings predict the prognosis of variant and classical type of posterior reversible encephalopathy syndrome (PRES)? Acta Radiol 54(10):1182–1190. doi:10.1177/0284185113491252 CrossRefPubMed Moon SN, Jeon SJ, Choi SS, Song CJ, Chung GH, Yu IK, Kim DH (2013) Can clinical and MRI findings predict the prognosis of variant and classical type of posterior reversible encephalopathy syndrome (PRES)? Acta Radiol 54(10):1182–1190. doi:10.​1177/​0284185113491252​ CrossRefPubMed
Metadaten
Titel
Factors associated with fatal outcome in posterior reversible encephalopathy syndrome: a retrospective analysis of the Berlin PRES study
verfasst von
Eberhard Siebert
G. Bohner
T. Liebig
M. Endres
T. G. Liman
Publikationsdatum
04.11.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Neurology / Ausgabe 2/2017
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-016-8328-4

Weitere Artikel der Ausgabe 2/2017

Journal of Neurology 2/2017 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.